OctreoPharm Sciences GmbH is a privately held biopharmaceutical company focusing on the development of radiopharmaceuticals. The Berlin (Germany) based company is located on the Biomedical Research Campus of Berlin-Buch and focuses specifically on the clinical development of radiopharmaceuticals to be used in nuclear medicine, molecular imaging and oncology for diagnosis and therapeutic control of cancer to ensure personalized medicine / Theranostics. Scope of Business: - Clinical development of radiopharmaceuticals for Dx and Tx based on inlicensed compounds - Contract development of radiopharmaceuticals (Dx and Tx) - Radiopharmaceutical services
View Top Employees from OctreoPharm Sciences GmbH| Website | https://www.octreopharmsciences.com |
| Revenue | $7.2 million |
| Funding | $7.2 million |
| Employees | 6 (3 on RocketReach) |
| Founded | 2009 |
| Address | Biomedical Research Campus Berlin-Buch, Robert-Roessle-Strasse 10, Bldg. B55, Berlin, Berlin 13125, DE |
| Phone | +49 30 94893360 |
| Fax | +49 30 94893364 |
| Industry | Pharmaceuticals, Drug Manufacturing & Research, Biotechnology, Healthcare |
| SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular OctreoPharm Sciences GmbH employee's phone or email?
OctreoPharm Sciences GmbH Questions
The OctreoPharm Sciences GmbH annual revenue was $7.2 million in 2023.
3 people are employed at OctreoPharm Sciences GmbH.
OctreoPharm Sciences GmbH is based in Berlin, Berlin.
The NAICS codes for OctreoPharm Sciences GmbH are [32, 3254, 325, 32541].
The SIC codes for OctreoPharm Sciences GmbH are [2834, 28, 283].
Related Companies
